Similar to previous reviews, our review found all anti-aminoacyl tRNA synthetase (ARS) antibody subtypes and anti-MDA5 antibodies to be associated with an increased risk of ILD relative to other MSA’s (34–36). Here, IFIH1 is linked to interstitial lung disease.